Tower Research Capital (TRC)’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Tower Research Capital (TRC)’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-76,087	Closed	-$193K	–	6341
2023 Q4	$193K	Buy	76,087 +44,211	+139%	+$103K	﹤0.01%	2128
2023 Q3	$76.2K	Buy	31,876 +13,172	+70%	+$29.2K	﹤0.01%	2196
2023 Q2	$43.2K	Sell	18,704 -26,112	-58%	-$73.7K	﹤0.01%	2702
2023 Q1	$114K	Buy	44,816 +40,949	+1,059%	+$117K	﹤0.01%	1750
2022 Q4	$10K	Sell	3,867 -16,455	-81%	-$45.9K	﹤0.01%	4120
2022 Q3	$59K	Buy	20,322 +8,983	+79%	+$37.8K	﹤0.01%	3016
2022 Q2	$51K	Buy	11,339 +7,120	+169%	+$42.4K	﹤0.01%	2866
2022 Q1	$34K	Buy	4,219 +3,619	+603%	+$31.9K	﹤0.01%	3048
2021 Q4	$7K	Sell	600 -3,407	-85%	-$40.8K	﹤0.01%	4965
2021 Q3	$49K	Buy	+4,007	New	+$45.2K	﹤0.01%	2987

Tower Research Capital (TRC)'s SLGC Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 76,087 shares — an estimated $193K sold.

Tower Research Capital (TRC) first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $193K in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Tower Research Capital (TRC) reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 76,087 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $193K.
Tower Research Capital (TRC) first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
Tower Research Capital (TRC)'s SomaLogic, Inc. Class A Common Stock position peaked at $193K in Q4 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.